儿童神经病学:以复发性缺血性卒中起病的Aicardi-Goutières综合征
本文报告一例以复发性缺血性卒中起病的年轻患者,检查发现冻疮、白质异常、脑萎缩及脑脊液干扰素-α升高,检出TREX1复合杂合变异确诊Aicardi-Goutières综合征(AGS)。排除其他病因后认为卒中由AGS所致,予托法替布联合抗血小板药物治疗,3个月随访期间无卒中复发。
要点
- 年轻卒中伴多系统受累时应考虑包括AGS在内的遗传性疾病。
- AGS可表现为复发性缺血性卒中,脑脊液干扰素-α升高及TREX1变异有助诊断。
- 本例予托法替布联合抗血小板药物,3个月随访无卒中复发。
核心结论
- 本文报告一例TREX1突变AGS患者以复发性缺血性卒中起病,认为小血管受累可能解释其缺血性卒中的发生。
研究设计与样本
- 本文为病例报告,描述一名以复发性缺血性卒中起病的年轻患者。
主要发现
- 评估发现冻疮、白质异常、脑萎缩及脑脊液干扰素-α升高,检出TREX1复合杂合变异,确诊AGS。
- 排除其他病因后认为卒中由AGS所致。
- 予托法替布联合抗血小板药物治疗,3个月随访期间无卒中复发。
关键数值与推荐
- 脑脊液干扰素-α升高,检出TREX1复合杂合变异,确诊AGS。
临床怎么用
- 作者认为,对于卒中且多系统受累的年轻患者,应考虑包括AGS在内的遗传性疾病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Aicardi-Goutières syndrome (AGS) is a rare, single-gene disorder, characterized by neurologic and skin involvement with an increased level of interferon-α (IFN-α) in the CSF. We describe the case of a young patient presenting with recurrent ischemic stroke. Evaluation revealed the presence of chilblains, white matter abnormalities, cerebral atrophy, and raised IFN-α in the CSF. Compound heterozygous variants of TREX1 were detected, confirming a diagnosis of AGS. After excluding other causes, we attributed the stroke to AGS. Tofacitinib, a Janus kinase inhibitor, was administered to our patient in addition to antiplatelet drugs. There was no recurrence of stroke during 3-month follow-up. This is a rare case of recurrent stroke in TREX1-mutated AGS. Small vessel involvement has been previously demonstrated to play a significant role in the pathogenesis of AGS. This microvascular mechanism might explain the occurrence of ischemic stroke in our patient. For young patients with stroke and multiple system involvement, genetic disorders including AGS should be considered.
引用
- Kuang SY, Li Y, Yang SL, et al. Child Neurology: Aicardi-Goutières Syndrome Presenting as Recurrent Ischemic Stroke. Neurology. 2022. PMID: 35803721. doi:10.1212/WNL.0000000000200952
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。